Gut microbiota and diabetes: The role of resistant starch demystified


Release time:

2024-06-07

The high amylose corn starch produced by Quan Yin Xiangyu (Beijing) Biotechnology Co., Ltd. has a straight chain content of up to 71%, which belongs to high dietary fiber, low GI raw materials, new high-quality carbohydrate raw materials, and has been certified by the authority of low GI; Dietary fiber structure is diverse (IDF+SDFP+SDFS), high-quality compound prebiotics, which can produce different kinds of short-chain fatty acids by acting on a variety of probiotics in intestinal flora. The essence is carbohydrate, but its resistant starch content is very high, so it is difficult to be digested in the human body. The satiety is very strong, and the blood glucose concentration curve will be in a very flat state.

The relationship between gut microbiota and diabetes has attracted increasing attention from researchers. Several studies have shown that the imbalance of gut microbiota may be closely related to the development and course of diabetes.

On the one hand, intestinal flora is involved in the regulation of energy metabolism and glucose homeostasis of the host. When beneficial bacteria such as Bifidobacterium and Lactobacillus are reduced, and toxin-producing bacteria such as Bacteroides and Clostridium tender are increased, it may lead to increased intestinal permeability, trigger systemic inflammatory response, and then affect insulin sensitivity and blood glucose control, and aggravate diabetes. On the other hand, gut microbiota may also influence the development of diabetes by regulating the immune response and endocrine system. For example, some intestinal bacteria can induce T cell differentiation into Th17 cells, promote the production of cytokines, these factors in the development of insulin resistance and type 1 diabetes play a key role.

In addition, some studies have found that the diversity and abundance of intestinal flora are different in patients with type 2 diabetes compared with non-diabetic patients, which may be related to insulin resistance and abnormal glucose metabolism. Therefore, gut microbiota may be an important intervention point in diabetes. Improving the balance of gut microbiota through dietary modification, prebiotic intake, probiotic supplementation, and gut microbiota transplantation (FMT) may help to prevent and treat diabetes.

The high amylose corn starch produced by Quan Yin Xiangyu (Beijing) Biotechnology Co., Ltd. has a straight chain content of up to 71%, which belongs to high dietary fiber, low GI raw materials, new high-quality carbohydrate raw materials, and has been certified by the authority of low GI; Dietary fiber structure is diverse (IDF+SDFP+SDFS), high-quality compound prebiotics, which can produce different kinds of short-chain fatty acids by acting on a variety of probiotics in intestinal flora. The essence is carbohydrate, but its resistant starch content is very high, so it is difficult to be digested in the human body. The satiety is very strong, and the blood glucose concentration curve will be in a very flat state.

Quanyin Xiangyu (Beijing) Biotechnology Co., LTD., "high-quality carbon and water manufacturers, resistant starch experts", the company insists on customer service, create value for customers, dig deep in the field of new healthy food raw materials, so that consumers at home and abroad can eat high-quality carbon and water, contribute to the healthy diet of human.

Quanyin Xiangyu (Beijing) Biotechnology Co., Ltd.

Address: A/ Beijing, B/Jnan Shandong

Working hours: Monday to Friday 9:00-18:00 GMT+8

Phone: +86-15911081400  (WeChat)

E-mail: Pekingxiangyu@gmail.com

XIANGYU

Li (WeChat)

XIANGYU

Li (WeChat)


copyright © 2023 Quanyin Xiangyu (Beijing) Biotechnology Co., Ltd.  Powered by www.300.cn | TAGS

Business license